“Embedded in Lupin is a formula for growth which fuels creativity, performance and innovation”
It was Dr. Desh Bandhu Gupta’s vision and passion which helped him grow a small dream into a large company with a global footprint.
The most advanced pharmaceutical product development
Progressing towards the development of
Producing quality medicines in areas of
Producing high quality affordable
and accessible biologics
Lupin facilitates ‘The Best of ACG’ in association with American College of Gastroenterology
Mumbai, December 20, 2019: Pharma major Lupin Limited (Lupin) announced an association with the American College of Gastroenterology (ACG) for a new initiative ‘The Best of ACG’. Under the terms of the agreement, ACG will take the best education materials from the ACG conference and will present it in Kolkata, Bangalore and Delhi in January 2020. Through this initiative, Lupin aims to bring in global educational material and provide access to latest developments in the field of gastroenterology in India.
The announcement was made by Dr. Mark Pochapin, President - ACG, Dr. Mahesh Kumar Goenka, India Governor - ACG and Dr. Nalini Guda, Prof. Medicine, University of Wisconsin, at the Asian Pacific Digestive Week 2019, which was held at Kolkata recently.
Dr. Mark Pochapin, President, ACG commented, “I am pleased to announce, together with my colleagues, an exciting new initiative called ‘The Best of ACG’, made possible by Lupin, our industry partner. We know that not everybody can come to the United States for our annual meeting, so we are taking the best educational material from the ACG conference and presenting it in three different cities in India. For our international ACG members, this will count towards the CME requirement for advancement to ACG fellowship known as FACG. We look forward to seeing you all at ‘The Best of ACG’ in India.”
Dr. Mahesh Goenka, India Governor, ACG supported this initiative by saying, “Anybody attending three such programs over a period of five years is eligible for Fellowship and this is a a meaningful achievement itself.”
Commenting on the announcement, Mr. Rajeev Sibal, President India Business, Lupin said, “We are glad to facilitate ‘The Best of ACG’ for gastroenterologists in India. This initiative brings in the best learning material from the American College of Gastroenterologist’s Annual Conference in the United States this year. ACG is the most renowned platform globally and we are happy to be associated with them.”
About the American College of Gastroenterology (ACG)
Founded in 1932, the American College of Gastroenterology (ACG) is an organization with an international membership of more than 14,000 individuals from 86 countries. The College’s vision is to be the pre-eminent professional organization that champions the evolving needs of clinicians in the delivery of high-quality, evidence-based, and compassionate health care to gastroenterology patients. The mission of the College is to advance world-class care for patients with gastrointestinal disorders through excellence, innovation, and advocacy in the areas of scientific investigation, education, prevention, and treatment. For more information, please visit www.gi.org. Follow ACG on Twitter @AmCollegeGastro
About Lupin Limited
Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally. The Company is a significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, CNS, GI, Anti-Infective and NSAID space and holds global leadership position in the Anti-TB segment.
Lupin is the 8th largest generics pharmaceutical company by revenues (June 30, 2019, Bloomberg LTM). The Company is the 3rd largest pharmaceutical player in the US by prescriptions (IQVIA MAT September 2019); 3rd largest Indian pharmaceutical company by global revenues (June 30, 2019, Bloomberg LTM) and 6th largest company in the Indian pharmaceutical market (IQVIA MAT September 2019).
For the financial year ended March 31, 2019, Lupin’s Consolidated sales and Net profits before exceptional items were at INR 163,694 million (USD 2.34 billion) and INR 9,466 million (USD 136 million) respectively. Please visit http://www.lupin.com for more information. You could also follow us on Twitter at – www.twitter.com/lupinglobal
CIN: L24100MH1983PLC029442 Registered Office: Lupin Ltd, 3rd Floor, Kalpataru Inspire, Off Western Express Highway, Santacruz (East), Mumbai 400 055
For further information or queries please contact:
Head – Investor Relations and M&A / Corporate Communications